Women with sickle cell disease have a significantly higher likelihood of developing preeclampsia than the general population, but a blood test could identify which patients have the greatest risk.A ...

This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy?

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment ...

Intellia Therapeutics NTLA is currently advancing two late-stage in vivo pipeline candidates – nex-z (or, NTLA-2001) for ...

SCD is an inherited blood disorder that affects millions of children worldwide, particularly in India and sub-Saharan Africa, ...

GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.

Disc Medicine will be enrolling 24 adults with SCD in its newly launched trial testing DISC-3405 at three doses for easing ...

A Gurugram hospital study reveals significant success in curing Sickle Cell Disease among children through bone marrow ...

Gurugram: Indian healthcare, doctors at FMRI, Gurugram, have reported exceptional success in curing children suffering from ...

The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and ...

AI-based analysis of OCT imaging may detect early signs of sickle cell maculopathy in pediatric patients, a study suggests.

Gurugram, have achieved a milestone in treating children with sickle cell disease (SCD) through bone marrow (stem cell) ...